|
China: SFDA Draft Aims to Bolster Quality of Device Clinical Trials
China’s proposed update to good clinical practice requirements for medical devices includes tougher provisions on ethics committees and human subject protections.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
|
Subscribe
Archives